Returning to Stanford University / Stanford d.school
I’m thrilled to be heading back to Stanford University and The Stanford d.school for the first time since graduating! I’ll be in the Bay Area next week from October 21st, representing Calla Lily Clinical Care 🌸. I’m excited to reconnect with professors, industry leaders, and former collegues on our exciting Callavid and Phlovid progress. I’d …
Top 6 Takeaways from the Women’s Health Innovation Summit in Boston
I feel like Boston is the place to be these days! I made my 3rd trip there in the last year to attend the Women’s Health Innovation Summit in Boston thanks to Kisaco Research and it was inspiring, to say the least. The event assembled leaders, innovators, and passionate professionals all focused on one mission: …
Calla Lily at CPHI Milan
We had an exciting & intense three days at CPHI Milan, connecting with business leaders from across the global life sciences industry, especially those passionate about advancing Womens Health. It was a pleasure to meet with our existing partners in person and explore exciting new materials and suppliers. We also uncovered unique opportunities for collaboration …
Visit to MIT Center for Gynepathology Research
I had the great honour of meeting with Linda Griffith, Professor of Biological and Mechanical Engineering, and MacVicar Fellow at Massachusetts Institute of Technology, where she leads the MIT Center for Gynepathology Research. I’ve long been inspired by Professor Griffith’s groundbreaking work, and now, with our progress and dedicated team & lab resources in place, …
Attending Tommy’s Preterm Birth Policy Lab
It has been an absolute pleasure and privilege participating at the Tommy’s Preterm Birth Policy Lab today hosted by Prof Catherine Williamson and Prof Anna David, moderated by Ross Pow (perfectly on schedule!). Experts from so many disciplines expressed their hopes and highlighted the obstacles on the road towards a real change in preventing PTB. …
Visit to Cambridge Design Partnership
We’ve made great strides in bringing in-house the R&D expertise and facilities needed to advance our vaginal drug delivery system. However, external partnerships remain key to achieving our ambitious goals. Our recent visit to Cambridge Design Partnership was a productive opportunity to align on our latest strategy and critical milestones, particularly around GMP manufacturing and …
“Unlocking the Potential of the Vaginal Microbiome” panel at WHIS Boston
Our Co-Founder Dr Lara Zibners will be at the Women’s Health Innovation USA 2024 summit in Boston to talk about the exciting vaginal microbiome space as part of the panel “Unlocking the Potential of the Vaginal Microbiome”. The advancing science is becoming impossible to ignore: reproductive tract dysbiosis or the lack of a healthy vaginal …
Dr. Emma Parry Joins as a Zinc NIHR Innovation Fellow
We’re delighted to welcome Dr. Emma Parry to our team as a Zinc NIHR Innovation Fellow! Emma brings invaluable expertise from her role as a clinical GP in Birmingham and as an academic GP at Royal Wolverhampton Hospitals NHS Trust. As we continue developing our patient-centric vaginal drug delivery system, Emma will play a key …
Pitching at the New York Venture Summit
Just returned from another productive trip to New York, where I also had the chance to pitch our Callavid drug delivery technology at the New York Venture Summit hosted by Young Startup Ventures at the Javits Center. Beyond engaging with potential investors, it was inspiring to connect with fellow medtech founders and explore exciting new …
Reflections from a Summer with Calla Lily Clinical Care
As I reflect on my summer internship with Calla Lily Clinical Care, I feel immense gratitude to the people who made my experience impactful. Navigating a new country and industry, I was a fish out of water, but everyone at CLCC welcomed me with open arms. I was encouraged to ask questions, explore new ideas, …